A pancreatic cancer researcher examines cancer cells under a microscope

Dedicated to improving patient outcomes, the Pancreatic Cancer Action Network (PanCAN) has announced the recipients of its 2019 research grants. Seven grants, totaling to more than $3 million, were awarded this year, bringing PanCAN’s total projected research investment to approximately $104 million, including its grants program and clinical and scientific initiatives.

Pancreatic cancer is a public health crisis, with diagnoses on the rise,” said Julie Fleshman, JD, MBA, president and CEO of PanCAN. “Through our donor-funded grants program, we are proud to support science focused on developing new and better treatments and early detection tools – without the generosity of donors, we simply would not be able to fund this vital research.”

PanCAN’s research grants program launched in 2003. In partnership with generous donors, the organization has awarded 174 grants to 170 scientists at 64 institutions to date.

The following researchers are recipients of 2019 PanCAN grants:

Two of the seven grants awarded support projects led by early-career researchers. Receiving a grant at this critical stage helps them further establish their careers and secure funding from other sources in the future. The other grantees received translational grants, which support projects aiming to take important discoveries from the laboratory to the clinic for patient benefit.

PanCAN and its Scientific Reviewers have also awarded five grant extensions to previously funded researchers with projects that are already in-progress. Extension recipients include:

“These grants enable pancreatic cancer researchers to pursue work that can make a major difference in our understanding of the disease and, most importantly, in patients’ lives,” said Lynn Matrisian, PhD, MBA, chief science officer at PanCAN.

She continued, “We are very excited about these projects and are extremely grateful to our generous donors for their partnership and all they make possible.”

Contact a Patient Central Associate
Support the Pancreatic Cancer Action Network’s urgent goal to drive progress and improve patients’ lives.